The Study of the Relationship Between TWEAK/Fn14, JAK/STAT3 and IDO in the Immune Microenvironment of Endometrium in Repeated Implantation Failure

计划入组 60 人 · 首次发布于 2016 年 11 月 18 日

Effects of Jianpi Lushi Jiedu Formula on postoperative recurrence of colorectal adenoma with spleen deficiency and dampness syndrome and its mechanism based on IL-6/JAK/STAT3 signaling pathway

A Study of DCR-STAT3 in Adults With Solid Tumors

计划入组 26 人 · 首次发布于 2023 年 10 月 24 日

JAK-989

exoASO-STAT3

JAN WALEWSKI

Poland

Vee Pak, LLC

United States

Jan Medical, Inc.

United States

BerGenBio's Bemcentinib Enters Clinical Trial for Advanced Lung Adenocarcinoma

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for STAT3 Inhibitor TTI-109, Plans 2027 Trial

First-in-Class STAT3 Inhibitor Shows Promise in Feline Head and Neck Cancer Trial with Human Applications